Verify Life Science LLC (CA, USA), health and life sciences company under Alphabet, recently announced its partnerships with four major pharmaceutical companies to allow them to move into the clinical trial market.
Collaboration in action: Nepali chemist receives 10 week bioanalytical training at three Dutch CRO’s
A Chemist and Quality Control Manager from a Nepali pharmaceutical company receives full training in bioanalytical method development and validation.
Amgen and Simcere announce collaboration in the development and distribution of biosimilars in China
An exclusive agreement between Amgen and Simcere has been announced in the co-development and commercialization of four undisclosed oncology and inflammation biosimilars.
Thermo Fisher Scientific announces collaboration with SRI International to advance small molecule research
Thermo Fisher Scientific announces collaboration with SRI International, incorporating SRI International’s BioCyc database collection to the Thermo Scientific Compound Discoverer 2.1 software platform.
Pharmaceutical Product Development (PPD) announces fifth renewal of contract with National Institutes of Health
Pharmaceutical Product Development, LLC has secured its renewal of a fifth contract with National Institutes of Health for HIV research support.
A multi-million pound research center specializing in biomedical research has been opened by SCIEX and the University of Manchester. The research facility will pilot a course of biomarker development projects that will help advance understanding of biomarkers in health and disease.
Interview with Chris Beaver (inVentiv Health Clinical) on the recent trends in sponsor requests and how the CRO relationship with Pharma/biotech is evolving
View our interview with Chris Beaver (inVentiv Health Clinical) at the 8th EBF Open Meeting.
In this installment of, ‘Running a successful CRO’, Afshin Safavi (Founder & Chief Scientific Officer, BioAgilytix) covers the important aspect of building partnerships with other CROs. Afshin reviews some of the initial factors that should be considered during the partner selection process and points out items for continued evaluation once an alliance is established.
Interview with Tim Sangster (Head of Bioanalysis and Immunology, Charles River) on the Reid Bioanalytical Forum and the skills gaps in analytical sciences
View our interview with Tim Sangster (Charles River Laboratories) at the 21st International Reid Bioanalytical Forum.
26 October 2015 Raleigh, NC – PRA Health Sciences (PRA) (NASDQ: PRAH) is pleased to…